Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody – the choice of chelator is essential

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Wuensche, Thomas E.; Stergiou, Natascha; Mes, Iris; Verlaan, Mariska; Schreurs, Maxime; Kooijman, Esther J. M.; Janssen, Bart; Windhorst, Albert D.; Jensen, Allan; Asuni, Ayodeji A.; Bang-Andersen, Benny; van Dongen, Guus A. M. S.; Beaino, Wissam; Vugts, Danielle J.

Journal title: Wuensche , T E , Stergiou , N , Mes , I , Verlaan , M , Schreurs , M , Kooijman , E J M , Janssen , B , Windhorst , A D , Jensen , A , Asuni , A A , Bang-Andersen , B , van Dongen , G A M S , Beaino , W & Vugts , D J 2022 , ' Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody – the choice of chelator is essential ' , Theranostics , vol. 12 , no. 16

Journal number: 7

Journal publisher: Ivyspring International Publisher

Published year: 2022

Published pages: 7067-7079

DOI identifier: 10.7150/thno.73509

ISSN: 1838-7640